VWF and von Willebrand disease 1: It is noteworthy that DDAVP’s effectiveness is predominantly in type 1 vWD, with limited to no efficacy in type 3 and certain subtypes of type 2 vWD, where the vWF protein is either absent or dysfunctional, respectively [39].